July 20, 2021
Article
CDC report chronicles 20 incidents of HBV infection among recipients between 2014 and 2019.
May 25, 2021
New shot fills a vital need, given poor efficacy of earlier options, researchers say.
April 30, 2021
With its mRNA COVID-19 vaccine authorized, the company is employing the technology to take aim at a variety of pathogens.
April 02, 2021
Simplifying access to hepatitis C virus care, including decentralized community-based care and task shifting to non-specialists, could improve testing and treatment for patients in settings with limited resources.
March 11, 2021
Series completion rates were different among patient groups, the study authors observed.
March 09, 2021
COVID-19 has further highlighted the need for innovative models that minimize face-to-face contact in HCV treatment.
February 23, 2021
An investigational HCV vaccine induced immunologic response and was well tolerated, but did not protect against infection.
November 02, 2020
Video
We asked a simple question to our IDWeek experts: has COVID-19 taken attention away from any greater infectious disease issues?
October 25, 2020
The presenting IDWeek author discusses the implication of promising phase 3 data for a new HBV vaccine.
October 24, 2020
A cross-specialty collaboration to mitigate inpatient cases of opioid use disorder has had early success; developers want to grow it.
